Lenvakast 10

Lenvakast-10mg

Composition: Lenvatinib 10mg

Therapeutic Class: Antineoplastic

Aprazer’s Lenvakast: Globally Prescribed and Trusted

Aprazer Healthcare is the leading global pharmaceutical company that manufactures a range of oncology care therapeutics.

• • WHO–GMP certified, Affordable oncology Medicines
• • Reaching the global markets, Aprazer Healthcare products are available worldwide.
• • Africa, South America, Southeast Asia, CIS countries.

What is Lenvakast?

Lenvakast is lenvatinib, which is used to treat several advanced-stage or metastatic cancers.

Uses of Lenvakast

• • Advanced Kidney Cancer
• • Radioactive Iodine-refractory Differentiated Thyroid Cancer
• • Advanced Hepatocellular Carcinoma
• • Endometrial Carcinoma

How does Lenvakast work?

• • It is a multiple tyrosine kinase inhibitor
• • It blocks several kinase enzymes
• • Inhibits new blood vessel formation in cancer cells
• • Cause cancer cells to starve and die.

Common Side Effects Include

• • High BP
• • Tiredness
• • Diarrhea
• • Nausea
• • Loss of appetite
• • Weight decline
• • Hand and foot syndrome
• • Pain in muscles and joints

Serious Side Effects

These are dose-dependent side effects that can be managed by supportive care.

• • Dizziness, seizures, and confusion.
• • Stroke or heart failure.
• • Elevated liver enzymes, acute liver failure.
• • GIT perforations
• • Internal bleeding
• • Thrombosis

Precautions

To be cautiously used in patients with:

• • Heart disease
• • Renal disorder
• • Liver disorder

Contraindications

• • Not to be used if any previous allergy or hypersensitivity to lenvatinib or any excipients.
• • Breastfeeding mothers
• • Pregnant women

Warning

To be used under medical prescription only.

Important Safety and Monitoring Information

Regular monitoring of the liver function, cardiac functions, blood pressure, neurological condition, and renal function.